155 related articles for article (PubMed ID: 30949212)
1. Hypoxia protects against the cell death triggered by oxovanadium-galactomannan complexes in HepG2 cells.
Meyenberg Cunha-de Padua M; Noleto GR; de Oliveira Petkowicz CL; Cadena SMSC; Bost F; Pouysségur J; Mazure NM
Cell Mol Biol Lett; 2019; 24():18. PubMed ID: 30949212
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of native and oxovanadium (IV/V) galactomannan complexes on HepG2 cells is related to impairment of mitochondrial functions.
Cunha-de Padua MM; Suter Correia Cadena SM; de Oliveira Petkowicz CL; Martinez GR; Merlin Rocha ME; Mercê ALR; Noleto GR
Carbohydr Polym; 2017 Oct; 173():665-675. PubMed ID: 28732911
[TBL] [Abstract][Full Text] [Related]
3. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effect of xyloglucan and oxovanadium (IV/V) xyloglucan complex in HepG2 cells.
Escaliante LADS; Busato B; Petkowicz CLO; Cadena SMSC; Noleto GR
Int J Biol Macromol; 2021 Aug; 185():40-48. PubMed ID: 34144065
[TBL] [Abstract][Full Text] [Related]
5. Two galactomannan preparations from seeds from Mimosa scabrella (bracatinga): Complexation with oxovanadium(IV/V) and cytotoxicity on HeLa cells.
Noleto GR; Petkowicz CL; Mercê AL; Noseda MD; Méndez-Sánchez SC; Reicher F; Oliveira MB
J Inorg Biochem; 2009 May; 103(5):749-57. PubMed ID: 19230977
[TBL] [Abstract][Full Text] [Related]
6. Galactomannan from Schizolobium amazonicum seed and its sulfated derivatives impair metabolism in HepG2 cells.
Cunha de Padua MM; Suter Correia Cadena SM; de Oliveira Petkowicz CL; Martinez GR; Rodrigues Noleto G
Int J Biol Macromol; 2017 Aug; 101():464-473. PubMed ID: 28347788
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation and leishmanicidal activity by galactomannan and its oxovanadium (IV/V) complex in vitro.
Adriazola IO; Evangelista do Amaral A; Amorim JC; Correia BL; Petkowicz CL; Mercê AL; Noleto GR
J Inorg Biochem; 2014 Mar; 132():45-51. PubMed ID: 24169303
[TBL] [Abstract][Full Text] [Related]
8. BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway.
Cosse JP; Rommelaere G; Ninane N; Arnould T; Michiels C
Biochem Pharmacol; 2010 Oct; 80(8):1160-9. PubMed ID: 20637734
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
Liu KG; Xie HH; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
[TBL] [Abstract][Full Text] [Related]
10. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
Dong Y; Narla RK; Sudbeck E; Uckun FM
J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
[TBL] [Abstract][Full Text] [Related]
12. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells.
Yuan GJ; Li QW; Shan SL; Wang WM; Jiang S; Xu XM
World J Gastroenterol; 2012 Sep; 18(34):4781-6. PubMed ID: 23002349
[TBL] [Abstract][Full Text] [Related]
14. Bax/Mcl-1 balance affects neutrophil survival in intermittent hypoxia and obstructive sleep apnea: effects of p38MAPK and ERK1/2 signaling.
Dyugovskaya L; Polyakov A; Cohen-Kaplan V; Lavie P; Lavie L
J Transl Med; 2012 Oct; 10():211. PubMed ID: 23088735
[TBL] [Abstract][Full Text] [Related]
15. Toxic effects of microcystin-LR on the HepG2 cell line under hypoxic and normoxic conditions.
Zhang X; Xie P; Zhang X; Zhou W; Zhao S; Zhao Y; Cai Y
J Appl Toxicol; 2013 Oct; 33(10):1180-6. PubMed ID: 22539157
[TBL] [Abstract][Full Text] [Related]
16. Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells.
Shen J; Zhu X; Wu Z; Shi Y; Wen T
Phytomedicine; 2022 Jan; 94():153793. PubMed ID: 34736000
[TBL] [Abstract][Full Text] [Related]
17. H
Pan X; Song X; Wang C; Cheng T; Luan D; Xu K; Tang B
Theranostics; 2019; 9(6):1794-1808. PubMed ID: 31037139
[No Abstract] [Full Text] [Related]
18. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3.
Azad MB; Chen Y; Henson ES; Cizeau J; McMillan-Ward E; Israels SJ; Gibson SB
Autophagy; 2008 Feb; 4(2):195-204. PubMed ID: 18059169
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
D'Cruz OJ; Dong Y; Uckun FM
Anticancer Drugs; 2000 Nov; 11(10):849-58. PubMed ID: 11142693
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia as a target for drug combination therapy of liver cancer.
Bowyer C; Lewis AL; Lloyd AW; Phillips GJ; Macfarlane WM
Anticancer Drugs; 2017 Aug; 28(7):771-780. PubMed ID: 28542038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
